about
Advances in Wilms Tumor Treatment and Biology: Progress Through International CollaborationClouds of oxygen: adolescents with cancer tell their story in music.Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.Wilms tumor in monozygous twins: clinical, pathological, cytogenetic and molecular case report.Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma.Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP studyGenomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.Adult Wilms' tumor: A monoinstitutional experience and a review of the literature.Wilms' tumor: past, present and (possibly) future.Celiac disease and childhood cancer.Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney.Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment.Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrencesA female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report.SCT for Wilms' tumour.Quantitative DNA methylation analysis improves epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.Treatment of relapsed Wilms tumors: lessons learned.Renal cell carcinoma in children and adolescents.An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour.Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review.Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.Mirror therapy for phantom limb pain in an adolescent cancer survivor.Five questions for assessing psychological problems in pediatric patients cured of neoplastic disease.Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma.Undifferentiated nasopharyngeal carcinoma in children and adolescents: comparison between staging systems.The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study.A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.Incidence and outcomes of patients with late recurrence of Wilms' tumor.Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan.No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
P50
Q28083988-95D9CF2A-D2D9-4BDD-99ED-08A588C1DEBEQ30369190-FFD09A99-BE33-4BD0-AE16-37418938AF75Q33207533-35D289A1-B3C7-4F50-8838-48C036CD8445Q33224957-9B4EFD36-EC47-4E26-9C4F-37C80E4A9ADFQ33325473-C7439033-AAF8-4FC9-8AB8-748B386C20B8Q33327077-8C672C85-7940-4F95-B784-76832D9365EEQ33343211-D09236B0-9D39-4707-A5A2-857C412962A9Q33413067-5914F35F-0189-4E87-9E86-C3DC9DF25FBCQ33918116-6FE2758A-6845-40F4-B8B9-F489D75D210BQ34190897-F92CDE2D-5D3F-4449-897A-CB83C2877A1CQ35799863-124F4A10-5B63-4AA8-ADB1-DEE3B98F190CQ35829965-0C247F29-3DF4-4D0B-8148-77000C50C88DQ36381288-3FD29AEE-B5BD-4A0C-95CD-910FAC17CBC8Q36516352-706D5BA6-F79D-46F9-92F9-672000A8A2D6Q36562222-00EE2CC1-AD5E-40D0-83C5-341E5B35E9CCQ36615949-79D35BCA-4653-4234-92B6-CC89DBB1A836Q36962452-6ADA2AB4-7B52-4810-8148-60F59FF87A3EQ37078335-DDFE8476-50B2-40A8-B8BA-DEA174BF9BFEQ37188465-6FE6E2D3-C3EC-4D1B-8C86-F4BF997F45BFQ37478188-07176380-7BAC-41E9-ABD7-3BAAD9432779Q37642795-C956FEDC-DB39-497A-AB2A-6EFC9FFAA39CQ37812610-C8DB0CAF-DD8D-446F-8016-CF6E929B9935Q38041750-03ED1167-BF21-45F2-A9C2-D45563DDAFE6Q38139615-B3D105C5-E789-4C5E-9EF8-68884917D3E8Q39504471-995FF0ED-FD4B-4BFB-847C-88AA719DEBE3Q39630181-F4E74406-0042-4183-80BB-4D48A17C1C34Q40467000-C1DBB102-52BF-44B2-8C53-21BB535EECAEQ40521540-59611360-8918-44C7-906E-6BD4DF98A21DQ40527175-EFE46B57-A770-447E-8652-D09AF143C6BFQ40683569-ED5DA454-D780-4BE8-8A63-AA9FC1A63D8BQ40958255-74CC60A0-B770-4D39-A325-DCF8066050ECQ43164381-1A286794-708D-4C4F-B92C-3FF3C00F4849Q43689954-21C83714-2755-4E5A-BBF8-CC91F4D6F24EQ43785491-52CCF361-B3D7-4452-A33D-44B0D90DBF82Q43822717-AA47ECCC-638F-473D-9EFA-5511A61C27FDQ43968973-4FADCBA5-C48A-437D-99E1-232799B4F6E4Q44028611-59D79033-07E6-42D6-9FD1-490048434EAAQ44178093-91576FE5-B84F-41C0-8CE4-D459B4A8FE9BQ44303307-6F5FE4B5-5AE0-4D1D-8EE2-14B48BA7F320Q44528077-3FEE51CC-7FDB-40C0-86AC-E95680F6E522
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Filippo Spreafico
@ast
Filippo Spreafico
@en
Filippo Spreafico
@es
Filippo Spreafico
@nl
Filippo Spreafico
@sl
type
label
Filippo Spreafico
@ast
Filippo Spreafico
@en
Filippo Spreafico
@es
Filippo Spreafico
@nl
Filippo Spreafico
@sl
prefLabel
Filippo Spreafico
@ast
Filippo Spreafico
@en
Filippo Spreafico
@es
Filippo Spreafico
@nl
Filippo Spreafico
@sl
P1053
K-7813-2016
P106
P1153
7005001567
P21
P31
P3829
P496
0000-0002-5587-3509